Effect of vitamin D in respiratory distress syndrome

Evaluation of the Effectiveness of Vitamin D ?Administration in the Treatment of Preterm Neonates with Respiratory Distress Syndrome

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20170307032933N4

Enrollment

Registered

2021-06-22

Start date

2021-06-28

Completion date

Unknown

Last updated

2021-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory distress syndrome of newborn. Respiratory distress syndrome of newborn

Interventions

Intervention 1: Intervention group 1: Daily 400 IU (1 cc) of vitamin D Drop (1000 IU, Alhavi company, Iran) for three weeks is administrated. Intervention 2: Intervention group 2: Daily 800 IU (1 cc)

Eligibility

Sex/Gender

All

Age

6 Months to 8 Months

Inclusion criteria

Inclusion criteria: Preterm newborn between 28-34 weeks gestation Preterm newborn admitted to NICU Preterm newborn with the confirmed respiratory distress syndrome based on clinical and chest X-ray findings

Exclusion criteria

Exclusion criteria: Neonates with neonatal sepsis Neonates with hypoxia Neonates with congenital disorders Neonates with feeding intolerance Newborn of diabetic mother

Design outcomes

Primary

Measure	Time frame
Mortality rate. Timepoint: Within admission period. Method of measurement: Reports of nurses or physicians.	—

Secondary

Measure	Time frame
Hospitalization duration. Timepoint: The first day and the last day of the patient's hospitalization. Method of measurement: Patient record.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactArash Malakian

Ahvaz University of Medical Sciences

malekianarash@gmail.com0098 61 3367543

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026